BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16545212)

  • 1. ["Ultra-early" antifibrinolytic treatment of subarachnoidal bleeding with tranexamic acid].
    Astrup J
    Ugeskr Laeger; 2006 Mar; 168(11):1107-11. PubMed ID: 16545212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study.
    Hillman J; Fridriksson S; Nilsson O; Yu Z; Saveland H; Jakobsson KE
    J Neurosurg; 2002 Oct; 97(4):771-8. PubMed ID: 12405362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of early rebleeding.
    Roos Y; Vermeulen M
    J Neurosurg; 2003 May; 98(5):1148-9; author reply 1149-50. PubMed ID: 12744388
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of early rebleeding.
    Schisano G; Nina P
    J Neurosurg; 2003 May; 98(5):1147-8; author reply 1148. PubMed ID: 12744387
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cyclocaprone prevents early rebleeding after subarachnoid hemorrhage and should be administered already prior to transfer to the department of neurology].
    Astrup J
    Ugeskr Laeger; 2003 Feb; 165(7):697-8. PubMed ID: 12617051
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of early rebleeding.
    Iplikçioglu AC; Bek S
    J Neurosurg; 2003 May; 98(5):1147; author reply 1148. PubMed ID: 12744386
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of early rebleeding.
    Lanzino G; Wang H
    J Neurosurg; 2003 May; 98(5):1146-7; author reply 1148. PubMed ID: 12744385
    [No Abstract]   [Full Text] [Related]  

  • 8. Considerable delay in diagnosis and acute management of subarachnoid haemorrhage.
    Larsen CC; Eskesen V; Hauerberg J; Olesen C; Romner B; Astrup J
    Dan Med Bull; 2010 Apr; 57(4):A4139. PubMed ID: 20385080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid in the preoperative management of ruptured intracranial aneurysms.
    Fodstad H; Liliequist B; Schannong M; Thulin CA
    Surg Neurol; 1978 Jul; 10(1):9-15. PubMed ID: 356311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial.
    Germans MR; Post R; Coert BA; Rinkel GJ; Vandertop WP; Verbaan D
    Trials; 2013 May; 14():143. PubMed ID: 23680226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update of the ULtra-early TRranexamic Acid after Subarachnoid Hemorrhage (ULTRA) trial: statistical analysis plan.
    Post R; Germans MR; Coert BA; Rinkel GJE; Vandertop WP; Verbaan D
    Trials; 2020 Feb; 21(1):199. PubMed ID: 32070395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy.
    Leipzig TJ; Redelman K; Horner TG
    J Neurosurg; 1997 Feb; 86(2):220-5. PubMed ID: 9010423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A successful treatment of life-threatening bleeding from polycystic kidneys with antifibrinolytic agent tranexamic acid.
    Vujkovac B; Sabovic M
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):589-91. PubMed ID: 16988557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial.
    Post R; Germans MR; Tjerkstra MA; Vergouwen MDI; Jellema K; Koot RW; Kruyt ND; Willems PWA; Wolfs JFC; de Beer FC; Kieft H; Nanda D; van der Pol B; Roks G; de Beer F; Halkes PHA; Reichman LJA; Brouwers PJAM; van den Berg-Vos RM; Kwa VIH; van der Ree TC; Bronner I; van de Vlekkert J; Bienfait HP; Boogaarts HD; Klijn CJM; van den Berg R; Coert BA; Horn J; Majoie CBLM; Rinkel GJE; Roos YBWEM; Vandertop WP; Verbaan D;
    Lancet; 2021 Jan; 397(10269):112-118. PubMed ID: 33357465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebleeding from ruptured intracranial aneurysms in North Eastern Province of Japan. A cooperative study.
    Tanno Y; Homma M; Oinuma M; Kodama N; Ymamoto T
    J Neurol Sci; 2007 Jul; 258(1-2):11-6. PubMed ID: 17512010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrinolytic therapy in the treatment of aneurysmal subarachnoid hemorrhage.
    Kassell NF; Haley EC; Torner JC
    Clin Neurosurg; 1986; 33():137-45. PubMed ID: 3491721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental studies on the diffusion of antifibrinolytic agents in fibrin thrombi. A contribution to intrathecal antifibrinolytic therapy in subarachnoid hemorrhages].
    Hindersin P; Senf L; Richter M; Endler S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):313-8. PubMed ID: 6179834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of tranexamic acid on bleeding time and haemostasis.
    Menzies SA; Hartley JA; Hitchcock ER; Rorke E; Gill JS
    Neurochirurgia (Stuttg); 1991 Sep; 34(5):141-3. PubMed ID: 1745318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of treatment of subarachnoid haemorrhage due to a ruptured cerebral aneurysm].
    González-Pérez MI
    Neurocirugia (Astur); 2006 Oct; 17(5):433-9. PubMed ID: 17106590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local antifibrinolytic treatment with tranexamic acid in hemophilic children undergoing dental extractions.
    Waly NG
    Egypt Dent J; 1995 Jan; 41(1):961-8. PubMed ID: 9497628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.